OncoSec Medical Inc (ONCSQ)

[chickpea598]

I think the next current combo trial update may help the stock price if we see continued positive results. Oncosec seemed very enthusiastic about the last data release from the current combo study especially with regards to the subset of 9 patients that had previous treatment with either Opdivo or Keytruda. I e-mailed IR twice and got no response back with regards to this subset of patients. I am still wondering about the specifics of that data. Did Oncosec mean that the subset of 9 patients were absolute failures to Opdivo or Keytruda which would mean that a response to the combo therapy with IL-12 and EP would be more significant. I am still confused about that. Ever since that data release the share price has tanked so I think the market is a bit confused about this too. Any thoughts on this. I would hate to think that Oncosec was sending mixed messages about that data. In the past they have answered all questions when I e-mailed IR.